Belite Bio
BLTE
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Belite Bio
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
1.10.2026
|
Verkauf |
Scholl, Hendrik Peter |
Chief Medical Officer |
166,9 $ |
82.659 $ |
|
8.9.2026
|
Verkauf |
Chuang, Hao-Yuan |
Chief Financial Officer |
196,3 $ |
3.528.139 $ |
|
8.9.2026
|
Verkauf |
Lin, Yu-Hsin |
Chief Executive Officer |
196,4 $ |
5.110.486 $ |
|
4.9.2026
|
Verkauf |
Chuang, Hao-Yuan |
Chief Financial Officer |
186,8 $ |
9.275.391 $ |
|
4.9.2026
|
Verkauf |
Lin, Yu-Hsin |
Chief Executive Officer |
186,8 $ |
13.972.062 $ |
|
12.8.2026
|
Verkauf |
Lin, Yu-Hsin |
Chief Executive Officer |
180,3 $ |
65.827 $ |
|
12.8.2026
|
Verkauf |
Chuang, Hao-Yuan |
Chief Financial Officer |
180,3 $ |
66.187 $ |
|
18.6.2026
|
Verkauf |
Scholl, Hendrik Peter |
Chief Medical Officer |
145,5 $ |
1.452.436 $ |
|
16.6.2026
|
Verkauf |
Scholl, Hendrik Peter |
Chief Medical Officer |
141,1 $ |
1.405.729 $ |
|
7.5.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
154,0 $ |
102.039 $ |
|
6.5.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
154,0 $ |
153.840 $ |
|
5.5.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
156,0 $ |
155.503 $ |
|
4.5.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
155,4 $ |
155.635 $ |
|
1.5.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
156,9 $ |
155.778 $ |
|
30.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
157,0 $ |
156.972 $ |
|
29.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
156,4 $ |
155.816 $ |
|
28.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
158,5 $ |
159.162 $ |
|
27.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
162,5 $ |
162.642 $ |
|
24.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
160,0 $ |
159.556 $ |
|
23.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
167,0 $ |
166.283 $ |
|
22.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
169,5 $ |
170.384 $ |
|
21.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
165,5 $ |
166.001 $ |
|
20.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
165,5 $ |
163.595 $ |
|
17.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
160,9 $ |
161.630 $ |
|
16.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
161,4 $ |
160.380 $ |
|
15.4.2026
|
Verkauf |
Mata, Nathan L. |
Chief Scientific Officer |
169,5 $ |
168.298 $ |
|
9.4.2026
|
Verkauf |
Chuang, Hao-Yuan |
Chief Financial Officer |
181,8 $ |
1.125.304 $ |
|
9.4.2026
|
Verkauf |
Chen, Wan-Shan |
Aufsichtsrat |
180,4 $ |
198.473 $ |
|
9.4.2026
|
Verkauf |
Lin, Yu-Hsin |
Chief Executive Officer |
181,8 $ |
1.669.339 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Verfolge die Insiderkäufe in Echtzeit per Push in unserem Telegram-Channel.
Jetzt beitreten